Sarissa Capital Management

Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:

Portfolio Holdings for Sarissa Capital Management

Companies in the Sarissa Capital Management portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Biogen Idec (BIIB) 25.95 643000 316.38
Ironwood Pharmaceuticals (IRWD) 17.41 13.53M +31% 10.09
Alkermes Plc 13.23 7.19M +89% 14.42
Allergan 10.56 467500 177.10
Jazz Pharmaceuticals 9.73 765000 +72% 99.74
Innoviva 9.36 6.24M 11.76
Intercept Pharmaceuticals In 9.28 1.16M +34% 62.96
Mersana Therapeutics 2.79 3.75M 5.83
Alexion Pharmaceuticals (ALXN) 1.55 135000 NEW 89.79
Regulus Therapeutics Inc 0.11 1.85M 0.46
Abbvie 0.01 1000 76.00
Mirati Therapeutics 0.01 1000 76.00

Past Filings by Sarissa Capital Management

View past SEC 13F filings by Sarissa Capital Management

View all filings